Orbit Discovery to Attend Bio-Europe Spring 2025

March 10, 2025

Orbit CEO, Neil Butt, and Simon Bushell (Business Development) will be attending Bio Europe Spring in Milan, Italy from March 17th-19th.

They are available to connect to talk about how Orbit’s peptide discovery platform is delivering fully validated targeting peptides and functional modulators—helping both big pharma and biotech accelerate therapeutic development.

Work With Us
As administrators Sue Staunton and Sandra Mundy manage the business, affairs and property of the Company and its agents and without personal liability.

Orbit Discovery Limited registered in England and Wales no.12850396 Registered office The White Building 1-4 Cumberland PlaceSouthampton SO15 2NP. VAT registration number 359593151’.

‍
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs
Contact Us